Aurinia Pharmaceuticals Inc
NASDAQ:AUPH

Watchlist Manager
Aurinia Pharmaceuticals Inc Logo
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Watchlist
Price: 8.28 USD -1.19% Market Closed
Market Cap: 1.2B USD
Have any thoughts about
Aurinia Pharmaceuticals Inc?
Write Note

Gross Margin
Aurinia Pharmaceuticals Inc

87.3%
Current
89%
Average
63.2%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
87.3%
=
Gross Profit
192.3m
/
Revenue
220.4m

Gross Margin Across Competitors

Country CA
Market Cap 1.2B USD
Gross Margin
87%
Country FR
Market Cap 6T USD
Gross Margin
0%
Country US
Market Cap 301B USD
Gross Margin
67%
Country US
Market Cap 162B USD
Gross Margin
60%
Country US
Market Cap 127.5B USD
Gross Margin
86%
Country US
Market Cap 115.4B USD
Gross Margin
78%
Country US
Market Cap 94.1B EUR
Gross Margin
76%
Country AU
Market Cap 138B AUD
Gross Margin
52%
Country US
Market Cap 88.6B USD
Gross Margin
87%
Country US
Market Cap 39.3B EUR
Gross Margin
75%
Country NL
Market Cap 34.1B EUR
Gross Margin
89%

Profitability Report

View the profitability report to see the full profitability analysis for Aurinia Pharmaceuticals Inc.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
87.3%
=
Gross Profit
192.3m
/
Revenue
220.4m
What is the Gross Margin of Aurinia Pharmaceuticals Inc?

Based on Aurinia Pharmaceuticals Inc's most recent financial statements, the company has Gross Margin of 87.3%.